Clinical Cancer Research · 2007 · 123 citations · 35 references
Our retrospective study provides compelling evidence that low mRNA and protein expression in the BRCA1/BRCA2 and XRCC5 genes occur in lung adenocarcinoma and squamous cell carcinoma, respectively, and that promoter hypermethylation is the predominant mechanism in deregulation of these genes. Alteration of the double-strand break repair pathway, perhaps by interacting with p53 and RB deregulation, is important in the pathogenesis of a subset of NSCLC.
35
Cancer Risks in BRCA2 Mutation Carriers
JNCI Journal of the National Cancer Institute · 1999 · 1.5K citations · Full text
Brca1 Controls Homology-Directed DNA Repair
Mary Ellen Moynahan, Joanne W Chiu, Beverly H. Koller et al. · Molecular Cell · 1999 · 1.2K citations · Full text
Cancer Incidence in BRCA1 Mutation Carriers
Douglas Thompson · JNCI Journal of the National Cancer Institute · 2002 · 1.1K citations · Full text